Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
PMID:

Abstract

BACKGROUND: To investigate the levels of VEGF in the systemic circulation of patients with type 1 ROP who received intravitreal injections of 1 mg (0.025 mL) aflibercept (IVA) or 0.625 mg (0.025 mL) bevacizumab (IVB).

Authors

  • Chung-Ying Huang
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • Reyin Lien
    Chang Gung University, College of Medicine, Taoyuan, Taiwan.
  • Nan-Kai Wang
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • An-Ning Chao
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • Kuan-Jen Chen
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • Tun-Lu Chen
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • Yih-Shiou Hwang
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • Chi-Chun Lai
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333.
  • Wei-Chi Wu
    Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 333. weichi666@gmail.com.